Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Walmsley

Showing results (51-60 of 199) with videos related to

Pageof 20
Sort By:
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2011
Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adultsAnita Rachlis, Marianne Harris, Richard Lalonde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2012
Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophyJeya T Nadarajah, Micaela Collins, Janet Raboud, et al.
Plos One|June 20, 2015
Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio IndexKathleen C Rollet-Kurhajec, Erica E M Moodie, Sharon Walmsley, et al.
Contemporary Clinical Trials|August 17, 2010
Design and methods of the MAINTAIN study: a randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infectionNeera Singhal, Dean Fergusson, Harold Huff, et al.
CMAJ Open|August 1, 2014
Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort studyJim Young, Martin Potter, Joseph Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2013
Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysisLaurence Brunet, Erica E M Moodie, Kathleen Rollet, et al.
PLOS Digital Health|May 9, 2023
Decentralized study of COVID Vaccine Antibody Response (STOPCoV): Results of a participant satisfaction surveyRizani Ravindran, Leah Szadkowski, Leif Erik Lovblom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2005
Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive womenPatrick Petignat, Catherine Hankins, Sharon Walmsley, et al.
Plos One|February 6, 2016
Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed PatientsJean-Guy Baril, Jonathan B Angel, M John Gill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study TeamAriela Noy, David T Scadden, Jeannette Lee, et al.
Pageof 20

Showing results (51-60 of 199) with videos related to

Sort By:
Pageof 20
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2011
Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adultsAnita Rachlis, Marianne Harris, Richard Lalonde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2012
Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophyJeya T Nadarajah, Micaela Collins, Janet Raboud, et al.
Plos One|June 20, 2015
Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio IndexKathleen C Rollet-Kurhajec, Erica E M Moodie, Sharon Walmsley, et al.
Contemporary Clinical Trials|August 17, 2010
Design and methods of the MAINTAIN study: a randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infectionNeera Singhal, Dean Fergusson, Harold Huff, et al.
CMAJ Open|August 1, 2014
Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort studyJim Young, Martin Potter, Joseph Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2013
Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysisLaurence Brunet, Erica E M Moodie, Kathleen Rollet, et al.
PLOS Digital Health|May 9, 2023
Decentralized study of COVID Vaccine Antibody Response (STOPCoV): Results of a participant satisfaction surveyRizani Ravindran, Leah Szadkowski, Leif Erik Lovblom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2005
Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive womenPatrick Petignat, Catherine Hankins, Sharon Walmsley, et al.
Plos One|February 6, 2016
Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed PatientsJean-Guy Baril, Jonathan B Angel, M John Gill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study TeamAriela Noy, David T Scadden, Jeannette Lee, et al.
Pageof 20